Wells Fargo & Company BIOMARIN PHARMACEUTICAL INC Transaction History

Wells Fargo & Company

19,500

Previous 5,201,500 99.63%

Previous $0 NaN%

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	N/A	-5,182,000 Reduced 99.63%	19,500 $0
Q1 2024 May 10, 2024	BUY	N/A	1,740,000 Added 50.27%	5,201,500 $0
Q4 2023 Feb 09, 2024	SELL	N/A	-240,000 Reduced 6.48%	3,461,500 $0
Q3 2023 Nov 13, 2023	BUY	N/A	689,000 Added 22.87%	3,701,500 $0
Q2 2023 Aug 15, 2023	SELL	N/A	-125,000 Reduced 3.98%	3,012,500 $0
Q1 2023 May 12, 2023	SELL	N/A	-22,000 Reduced 0.7%	3,137,500 $0
Q4 2022 Feb 13, 2023	SELL	N/A	-98,000 Reduced 3.01%	3,159,500 $0
Q3 2022 Nov 14, 2022	SELL	N/A	-38,000 Reduced 1.15%	3,257,500 $3.24 Million
Q2 2022 Aug 12, 2022	SELL	N/A	-936,000 Reduced 22.12%	3,295,500 $3.26 Million
Q1 2022 May 16, 2022	BUY	N/A	1,251,000 Added 41.97%	4,231,500 $4.26 Million
Q4 2021 Feb 14, 2022	SELL	N/A	-106,000 Reduced 3.43%	2,980,500 $3.12 Million
Q3 2021 Nov 15, 2021	BUY	N/A	32,000 Added 1.05%	3,086,500 $3.16 Million
Q2 2021 Aug 16, 2021	SELL	N/A	-645,000 Reduced 17.43%	3,054,500 $3.17 Million
Q1 2021 May 13, 2021	SELL	N/A	-215,000 Reduced 5.49%	3,699,500 $3.74 Million
Q4 2020 Feb 09, 2021	BUY	N/A	1,915,500 Added 95.82%	3,914,500 $4.2 Million
Q3 2020 Nov 05, 2020	SELL	N/A	-143,000 Reduced 6.68%	1,999,000 $2.1 Million
Q2 2020 Aug 13, 2020	SELL	N/A	-62,000 Reduced 2.81%	2,142,000 $2.62 Million
Q1 2020 May 14, 2020	BUY	N/A	2,204,000 New	2,204,000 $2.31 Million

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.